Next Level Athletics – Trademark Portfolio

Entity Type: 16

Next Level Athletics holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HER OMEGAS. The owner is based in Granada Hills, CA.

17545 Regency Way

Granada Hills, CA 91344

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Next Level Athletics's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Next Level Athletics have?

Next Level Athletics has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 5 cancelled.

What trademark classes does Next Level Athletics file in?

Next Level Athletics files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Next Level Athletics's most well-known trademarks?

Next Level Athletics's registered trademark portfolio includes well-known marks such as HER OMEGAS. These are among 1 currently registered trademark in the portfolio.

What is Next Level Athletics's trademark registration success rate?

Next Level Athletics has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.